Insider Trading: Furiex Pharmaceuticals Inc (FURX.O)

FURX.O on Nasdaq

75.24USD
17 Apr 2014
Price Change (% chg)

$-1.88 (-2.44%)
Prev Close
$77.12
Open
$76.98
Day's High
$78.10
Day's Low
$74.38
Volume
199,354
Avg. Vol
336,721
52-wk High
$121.97
52-wk Low
$32.01

Search Stocks
ESHELMAN FREDRIC N Options Exercised: 0
Trade Date: Wednesday, 30 May 2012 Price: 20.06
Title: Director and Beneficial Owner Shares Held: 2,696,655
Type Traded: Direct Net Change in Shares This Filing: 120,394

Institutional Holders

% Shares Owned: 66.79%
# of Holders: 110
Total Shares Held: 7,217,314
3 Mo. Net Change: 798,707
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 8
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

Fredric Eshelman

64 2009 Chairman of the Board

June Almenoff

56 2012 President, Chief Medical Officer, Principal Executive Officer, Director

Sailash Patel

55 2013 Chief Financial Officer and Vice President - Strategic Development

Paul Covington

57 2010 Senior Vice President - Clinical Development and Operations

Gail McIntyre

50 2010 Senior Vice President - Research

Peter Corr

65 2010 Independent Director

Wendy Dixon

57 2010 Independent Director

Stephen Kaldor

51 2010 Independent Director
Search Stocks